版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
SCI期刊投稿常识学科办/研究生工作处世界六大检索系统
美国《科学文献索引》(SCI)美国《工程索引》(EI)美国《国际科学技术会议》(ISTP)美国《化学文摘》(CA)英国《科学文摘》(SA)日本科技文献速报(CBST)创新点originality语言Language成功关键:Pathwaystosuccess医学科研论文的基本结构与要求(2)
9.插图说明Figurelegends10.插图Figures11.表格Tables12.照片和说明Platesandexplanations1.
引言
Introduction背景–说明研究问题的现状或历史意义–说明研究的意义或必要性进展–说明以前的发现、报告或研究目的–说明本研究的目的范围–说明要研究问题的具体范围
2.
材料与方法
MaterialsandMethods
研究设计(studydesign)研究对象性质(identity)处理/干预方法(intervention)测定/观察手段(measurement)统计方法与分析(statistics)3.
结果Results
让研究的客观结果说话,不要添枝加叶(用叙事方式来描述)
Letyourresultsspeakforthemselvesanddon’tembellishThelocalizationofα7nAChRonmacrophageinmiceToobservewhetherα7nAChRcouldbelocalizedonmacrophageinmice,theabdominalsolutionwastakenfrommice,andthenmacrophageswereisolatedfromabdominalsolutionandculturedfordetectionofthelocalizationofα7nAChR.Immunofluorescenceexperimentwascarriedoutasdescribedinmethods;theresultisshowninFig.2thatα7nAChRcouldbelocalizedonthesurfaceofmacrophageinmice.
4.讨论Discussion简要说明研究背景background简要介绍总的发现generalfindings介绍具体要点introductionofpoints与先有发现(若有)进行比较comparisoninthecontextofotherstudies意义suggestedmeaning结论conclusion前瞻研究futurestudies5.致谢Acknowledgements致谢词和致谢方式必须征得受谢人或单位的同意(包括项目资助来源、实验方法和技术提供帮助的人、馈赠试剂和细胞株的人、帮助修改稿件的人等)AcknowledgementsWethankDrJaw-KangChangforthedonationofanti-serumagainstEM1andEM2usedinthepresentstudy.ThisworkwassupportedbythegrantsfromNationalNaturalScienceFoundationofChina(30560145)andtheScientificandTechnologicalProgramoftheDepartmentofEducation,JiangxiProvince,China.TheauthorsthankDr.YouWan(NeuroscienceResearchInstitute,PekingUniversity,China)forhishelpinpreparingthemanuscript.
7.插图说明Figurelegends插图另页双行打印
Typeoutlegendsforillustrations
▲usingdoublespacing
▲startingonaseparatepageFig.1.Theenhancedantinociceptiveeffectof100HzEAintheCFA-inflammatorypainrats.20CFA-injectedratswererandomlydividedintotwogroupsofCFAandCFAplusEA.Another20normalratswerealsodividedrandomlyintotwogroupsofnormalandnormalplusEA.100HzEAwereappliedfor30min,tailflicklatency(TFL)wasmeasuredevery10minduringEA,dataareexpressedasmeansSEM.**P<0.01,§§P<0.01comparedwiththecorrespondingcontrolgroup.#P<0.05comparedwiththenormalplusEAgroup.n=10.
8.图表FiguresandTables插图要按杂志的版面大小比例进行压缩;不要把插图拍成照片
Designyourfiguresfortheappropriatereduction投稿文件排列顺序:1.附信(给编辑部的信)Coverletter2.标题页Titlepage3.摘要页Abstractpage4.正文(无姓名、单位、地址)Body5.图表说明Figurelegends6.图表FiguresandTables4)对研究成果可能引起的利益冲突(interestconflict)或法律纠纷(legalliability)问题,如多中心研究的成果归属问题,与资助单位的利益分配问题,加以说明5)所有作者的签名(signature),超过25个作者时,签名到第25个作者6)其他要说明的问题7)写信人,即通讯作者(correspondingauthor)的详细地址和联系方式,包括电话、传真和E-mail复信示例Acoverletter(1)DearEditors:WouldyoupleasekindlyacceptourmanuscriptentitledDiscreteeffectsofcardiacnorepinephrineonpost-ischemicmyocardialdysfunctioninhypertensiverats?【投稿愿望】Wethinkthatthemostinterestingresultofthisstudyisthatdifferentdegreesofcardiacnorepienphrinereductioninhypertrophiedheartsledtoquitedifferentpatternsofrecoveryinposat-ischemicheartfunction.Sincereductionofcardiacnorephrinewithreserpinedidnotresultindepressedmyocardialcontractility,itisofpotentialimportancewhensuchinterferenceisutilizedtodeterfurtherdysfunctioninheartsduringischemia.【本研究的意义】
Partsofthepresentresultswerepresentedatthe11thJapan-ChinaJointMeetingonPharmacologyheldinChinaon25-27Aug.2000andwillbepublishedintheformofabstractinthejournalActaPharmacologicaSinicabytheendofthisyear.HereenclosedarethreecopiesoftheabstractsubmittedtoActaPharmacologicaSinica.Thepresentworkisnotcurrentlyunderconsiderationforpublicationelsewhere.【对内容重复等问题加以说明】
ThankyouverymuchSincerelyyours,CHENHong,MD,PhD(signature)复信示例Acoverletter(2)DearDr.AbelLajtha,Re:SubmissiontoNeurochemicalResearchWesubmitanewmanuscripttoyouentitled“ElectroacupunctureeffectsinaratmodelofcompleteFreund’sadjuvant-inducedinflammatorypain:antinociceptiveeffectsenhancedandtolerancedevelopmentaccelerated”.Thismanuscriptrepresentstheoriginalresearchresultsnotpreviouslypublished
anywhereinanyform,inwholeorinpartanditisnotbeingconsideredforpublication
elsewhere.Allco-authorsagreetothesubmissionofthismanuscript.Ifyouhaveanyquestions,pleasefeelfreetoletmeknow.
Wearelookingforwardtohearingfromyousoon.Sincerely,ChengHuang,M.S.DepartmentofPhysiologyGannanMedicalUniversity1YixueyuanRoadGanzhou341000,Jiang-XiProvince,ChinaE-mail:2.标题页Titlepage(1)根据投稿要求,论文标题及有关著录内容应单独双行打印,称为“标题页”(Titlepage),放在附信(coverletter)之后、摘要页(abstractpage)之前,其内容包括:标题页Titlepage(2)标题(Titleofthearticle)所有作者的姓名及其最高学位、所属单位(nameofeachauthor,thehighestacademicdegreeandinstitutionalaffiliation)3)弃权者(若有)(disclaimers,ifany)4)研究工作的归属部门或单位名称(thenameofthedepartmentandinstitutiontowhichtheworkshouldbeattributed)标题页Titlepage(3)5)
负责通讯和校稿作者的姓名和详细地址(thenameandaddressoftheauthorresponsibleforcorrespondenceandproofaboutthemanuscript)6)申请副本联系人姓名和地址(thenameandaddressoftheauthortowhomrequestsforreprints(offprint)shouldbeaddressed);Offprintsarenotofferedfreeofcharge!7)不超过40个字母(包括间隔)的页眉标题(ashortrunningheadofnomorethan40lettersandspacesatthefootofthetitlepage)8)资助、设备、药品来源(sourcesofsupportintheformofgrants,equipment,drugs,orallofthese)标题页示例(2)Title:CCKBreceptorantagonistL365,260potentiatestheefficacytoandreverseschronictolerancetoelectroacupunctureinducedanalgesiainmiceAuthors’name:ChengHuanga,b,Zhi-PingHua,Shao-ZuJianga,Han-TingLia,YouWanb,Allauthors’address:aDepartmentofPhysiology,GannanMedicalUniversity,1YixueyuanRoad,Ganzhou341000,PRChina.bNeuroscienceResearchInstitute,PekingUniversity.KeyLaboratoryofNeuroscience,MinistryofEducation.38XueyuanRoad,Beijing100083,PRChina.Correspondingauthor:YouWan,Ph.D.NeuroscienceResearchInstitutePekingUniversity38XueyuanRoadBeijing100083,ChinaTel.andFax:+86-10-8280.1151E-mail:
3.摘要页Abstractpage1.论文标题Title2.论文摘要Abstract3.关键词key/indexingwords6.投稿常用术语(1)Corresponding/correspondenceauthor:通讯作者,负责联系出版、校稿事宜的作者author
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
评论
0/150
提交评论